The urinary levels of 11-deoxy-17-ketosteroids and estrogen receptor content in tumor tissues were determined in 76 patients with early breast cancer. Twenty-six postmenopausal and 16 premenopausal patients with estrogen receptor negative tumors were found to excrete subnormal amounts of 11-deoxy-17-ketosteroids while 22 postmenopausal and 12 premenopausal patients with estrogen receptor containing tumors excrete near normal levels of urinary 11-deoxy-17-ketosteroids.
|Original language||English (US)|
|Number of pages||4|
|Journal||European Journal of Cancer (1965)|
|State||Published - Jul 1977|
Bibliographical noteFunding Information:
Accepted 7 December 1976. "~This work was supported in part by a grant from the Graduate School, University of Minnesota. Part of this work was conducted at the American University of Beirut, Lebanon while on sabbatical leave from the University of Minnesota.
Copyright 2014 Elsevier B.V., All rights reserved.